9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma Ugolkov, Andrey V.; Bondarenko, Gennadiy I.; Dubrovskyi, Oleksii; More Ugolkov, Andrey V.; Bondarenko, Gennadiy I.; Dubrovskyi, Oleksii; Berbegall, Ana P.; Navarro, Samuel; Noguera, Rosa; O’Halloran, Thomas V.; Hendrix, Mary J.; Giles, Francis J.; Mazar, Andrew P. Less Anti-Cancer Drugs. 29(8):717-724, September 2018. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib McGrath, Alexandria C.; Sandhu, Geeta; Walpole, Euan; More McGrath, Alexandria C.; Sandhu, Geeta; Walpole, Euan; McCaffrey, Elizabeth; Hollingworth, Samantha A. Less Anti-Cancer Drugs. 29(8):786-790, September 2018. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
Dabrafenib and trametinib treatment-associated fevers in metastatic melanoma causing extreme elevation in procalcitonin in the absence of infection Clay, Timothy D.; Bowyer, Samantha E. Clay, Timothy D.; Bowyer, Samantha E. Less Anti-Cancer Drugs. 29(8):802-805, September 2018. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
